文献速递主动脉疾病

基于肠系膜下动脉通畅性与腰动脉负荷的EVAR术后囊腔扩大和再干预术前风险分层

Preoperative risk stratification for sac enlargement and reintervention using inferior mesenteric artery patency and lumbar artery burden after endovascular aneurysm repair.
PubMed 文献 · J Vasc Surg · 2026-09-21

该回顾性单中心研究纳入335例腹主动脉瘤EVAR患者,按术后肠系膜下动脉通畅性和残余腰动脉数量分层。研究发现残余腰动脉越多,II型内漏发生率越高;非通畅IMA且≥3条残余LA或通畅IMA且≥2条残余LA为高风险,其10年免于囊腔扩大>5mm和再干预率显著低于低风险组。

要点

  • 残余腰动脉每增加一条,囊腔扩大>5mm风险增加83%,再干预风险增加79%。
  • 非通畅IMA且≥3条残余LA或通畅IMA且≥2条残余LA定义为高风险。
  • 高风险组10年免于囊腔扩大>5mm为35%,低风险组为92%。

核心结论

  • EVAR术后残余腰动脉越少, outcomes越好;最佳阈值因IMA通畅性而异,有助于风险分层和治疗规划。

研究设计与样本

  • 回顾性单中心研究,纳入335例因腹主动脉瘤接受EVAR的患者,按术后IMA通畅性和残余LA数量分层,采用Kaplan-Meier分析和预设二分法确定最佳风险分层截断值。

主要发现

  • 335例患者中,II型内漏发生率随残余LA负荷增加而升高,且IMA通畅者始终高于非通畅者(所有比较P < .001)。
  • 高风险组(非通畅IMA且≥3条残余LA或通畅IMA且≥2条残余LA)10年免于囊腔扩大>5mm为35%,低风险组为92%(P < .0001)。
  • 高风险组10年免于再干预为70%,低风险组为98%(P < .0001)。
  • 多变量Cox回归中,每增加一条残余LA独立与囊腔扩大>5mm风险增加相关(HR 1.83;95%CI 1.59-2.12;P < .001),也与再干预风险增加相关(HR 1.79;95%CI 1.39-2.32;P < .001)。
  • IMA通畅独立与囊腔扩大相关,但与再干预无关。

关键数值与推荐

  • 高风险定义:非通畅IMA且残余LA≥3条,或通畅IMA且残余LA≥2条。
  • 每增加一条残余LA,囊腔扩大>5mm的HR为1.83(95%CI 1.59-2.12;P < .001),再干预的HR为1.79(95%CI 1.39-2.32;P < .001)。
  • 高风险组10年免于囊腔扩大>5mm为35%,低风险组为92%(P < .0001)。
  • 高风险组10年免于再干预为70%,低风险组为98%(P < .0001)。
  • II型内漏发生率随残余LA负荷增加而升高,IMA通畅者高于非通畅者(P < .001)。

临床怎么用

  • 术前可根据IMA通畅性和残余腰动脉数量对EVAR患者进行风险分层,识别高风险患者。
  • 对高风险患者(非通畅IMA且≥3条残余LA或通畅IMA且≥2条残余LA)应加强术后监测和随访,警惕囊腔扩大和再干预。

局限性

  • 回顾性单中心研究,样本量335例,结果需外部验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To determine the optimal number of residual lumbar arteries (LAs) based on inferior mesenteric artery (IMA) patency and assess their associations with sac enlargement and reintervention after endovascular aneurysm repair (EVAR). METHODS: This retrospective single-center study included 335 patients who underwent EVAR for abdominal aortic aneurysm. Patients were stratified by postoperative IMA patency and residual LA count. Kaplan-Meier analyses with three prespecified dichotomizations were used to determine optimal risk-stratification cutoffs. RESULTS: Among 335 included patients, type II endoleak incidence increased with greater residual LA burden and was consistently higher in those with a patent IMA than those with a nonpatent IMA (P < .001 for all comparisons). Based on previously reported long-term open repair outcomes, patients with a nonpatent IMA and ≥3 residual LAs or a patent IMA and ≥2 residual LAs were classified as high risk. Kaplan-Meier analysis showed significantly lower 10-year freedom from sac enlargement >5 mm and reintervention in the high-risk than in the low-risk group (35% vs 92% and 70% vs 98%, respectively, both; P < .0001). In multivariable Cox regression, each additional residual LA was independently associated with increased risks of sac enlargement >5 mm (hazard ratio, 1.83; 95% confidence interval, 1.59-2.12; P < .001) and reintervention (hazard ratio, 1.79; 95% confidence interval, 1.39-2.32; P < .001), whereas patent IMA was independently associated with sac enlargement but not with reintervention. CONCLUSIONS: Following EVAR, fewer residual LAs were associated with improved outcomes; optimal thresholds differed by IMA patency and may aid risk stratification and treatment planning.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Manabe K, Kawajiri H, Kobayashi T, et al. Preoperative risk stratification for sac enlargement and reintervention using inferior mesenteric artery patency and lumbar artery burden after endovascular aneurysm repair. J Vasc Surg. 2026. PMID: 42767437. doi:10.1016/j.jvs.2026.09.017

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。